From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Keyword results: IXICO


IXICO – contract award, but how’s the cash burn?...

Biopharmaceutical data analytics company IXICO (IXI) has announced it has been selected for an open-label Phase I/II dose finding study, emphasising it “reflects the confidence of our clients in the use of our services”. So what of a share price slightly ahead to 43.5p, but comparing to 58.5p in December?…


IXICO – full-year results, ‘resilience built in’?

Biopharmaceutical data analytics company IXICO (IXI) has announced results for its year ended 30th September 2021 and the shares are currently more than 16% higher to 58.5p. However that compares to circa 84.5p when I previously wrote in October, so what’s the story now?…


IXICO – emphasises “ahead of market expectations”, but what does that mean financially and what’s to come?...

Biopharmaceutical data analytics company IXICO (IXI) has made a trading update including that year ended 30th September 2021 EBITDA is “expected to be materially ahead of market expectations of £1.2 million and prior year (2020: £1.3 million)”. Why then is the share price little changed at circa 84.5p?…


IXICO – “successfully grown its pipeline of new opportunities”, so why are the shares further lower?...

Having been above 100p as recently as April, shares in biopharmaceutical data analytics company IXICO (IXI) are currently further lower at 72p despite a trading update including that “the company has successfully grown its pipeline of new opportunities”. So what’s going on?…


ShareProphets readers tips for 2020 competition – end March update

Having asked for readers tips for 2020 for the prize of 1/2 litre of Tom Winnifrith's Greek Hovel olive oil (2020 harvest) HERE, the following is an update on performance at the end of March (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM casino and the stocks not to have been suspended at the commencement of 2020)...

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Complete Coverage

Recent Comments

Time left: 18:41:34